Regions of beta 2 and beta 4 responsible for differences between the steady state dose-response relationships of the alpha 3 beta 2 and alpha 3 beta 4 neuronal nicotinic receptors by unknown
Regions  of [32 and [34 Responsible 
for Differences  between  the Steady State 
Dose-Response  Relationships  of the 0L3132 
and ct3134 Neuronal  Nicotinic  Receptors 
B.N.  COHEN,*  A.  FIGL,  "t  M.W.  QUICK,w C.  LABARCA,w 
N.  DAVIDSON,  w and  H.A.  LESTER  w 
From  the  *Division of Biomedical  Sciences, University  of California,  Riverside,  Riverside, 
California  92521-0121;  r  of Chemistry  and Chemical  Engineering and ~Division of 
Biology, California Institute of Technology, Pasadena,  California 91125 
ABSTRACT  We  constructed  chimeras  of the  rat  [32  and  [34  neuronal  nicotinic 
subunits  to locate the regions that contribute to differences between the acetylcho- 
line (ACh) dose-response relationships  of the cx3132 and cx3134 receptors. Expressed 
in Xenopus oocytes, the r  receptor displays an ECs0 for ACh  ~ 20-fold less than 
the ECs0 of the ct3134 receptor. The apparent Hill slope (napp) of ~t3132 is near one 
whereas  the ct3134 receptor displays an  nap  p near two.  Substitutions within  the first 
120  residues  convert  the  EC50 for ACh  from  one  wild-type  value  to  the  other. 
Exchanging just  [32:104-120 for the corresponding region of [34 shifts the ECs0 of 
ACh dose-response relationship  in the expected direction but does not completely 
convert the ECs0 of the dose-response relationship from one wild-type value to the 
other. However, substitutions in the [32:104-120 region do account for the relative 
sensitivity of the ~t3132 receptor to cytisine,  tetramethylammonium,  and ACh. The 
expression  of [34-like  (strong)  cooperativity  requires  an  extensive  region  of [34 
([34:1-301). Relatively short [32 substitutions ([32:104-120) can reduce cooperativity 
to [32-like values. The results suggest that amino acids within the first  120 residues 
of [32 and the corresponding region of [34 contribute to an agonist binding site that 
bridges the et and [3 subunits in neuronal nicotinic receptors. 
INTRODUCTION 
Both the ot and non-~t subunits of the nicotinic acetylcholine receptor (nAChR) play a 
role  in  the  activation  of the  receptor  by  agonist  (reviewed  in  Deneris,  Connolly, 
Rogers,  and  Duvoisin,  1991;  Karlin,  1993;  Papke,  1993).  Although  many  studies 
show that agonist binds to the tx subunit  (reviewed in Karlin,  1993),  present opinion 
is  divided  about  the  possibility  of an  agonist  binding  site  at  the  tx/non-et  subunit 
interface  (Cockcroft,  Osguthorpe,  Barnard,  and  Lunt,  1990;  Karlin,  1993;  Unwin, 
1993). The evidence for an ~x-only binding site is that 9-~ images of Torpedo nAChRs 
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reveal a unique cleft within the a  subunit that could act as an agonist binding pocket 
(Unwin,  1993). However, there is no evidence that agonists actually bind within this 
cleft and contact only ec-subunit residues. On the other hand, previous experiments 
show that (a) the muscle-type a  subunit (al) binds nicotinic agonists with appreciable 
affinities only if it is complexed with a non-c~ subunit (Blount and Merlie,  1988) and 
(b)  the  competitive antagonist d-tubocurarine  (d-l'C)  photolabels  residues  on the  -y 
and G subunits of Torpedo nAChRs (Pedersen and Cohen,  1990; Chiara and Cohen, 
1992), which is strong evidence for a direct participation of the non-et subunits in an 
agonist  binding  site.  However, dTC  is  a  larger  molecule  than  ACh  and  may  not 
contact  exactly  the  same  residues  that  ACh  does.  Large  quantities  of purified 
neuronal nAChRs are not available for direct biochemical and structural analyses of 
potential  agonist  binding  sites.  We  have  exploited  the  fact  that  a3132 and  et3134 
neuronal nAChRs expressed in Xenopus oocytes display different relative sensitivities 
to the ganglionic agonists, cytisine (CYT), tetramethylammonium (TMA), acetylcho- 
line (ACh) and nicotine (Leutje and Patrick, 1991; Figl, Cohen, Quick, Davidson, and 
Lester, 1992), and different dose-response relationships for ACh (Couturier, Erkman, 
Valera, Rungger, Bertrand, Boulter, Ballivet, and Bertand, 1990; Cachelin andJaggi, 
1991; Leutje, Piattoni, and Patrick, 1993; Wong, Mennerick, Clifford, Zorumski, and 
Isenberg,  1993), to locate the residues of 132 and 134 involved in agonist activation of 
the receptor. 
In an earlier study on coexpressed c~3 and  13  subunits,  we used  134"132 chimeras. 
Extending  the  134  NHe-terminal  region  of a  chimera  from  residues  134:1-105  to 
134:1-122  (Fig.  1)  changed  the  CYT/ACh  and  TMA/ACh  response  ratios  from 
~3132-1ike  (132-like) to  c~3134-1ike (134-like) levels  (Figl  et  al.,  1992).  These  data 
suggested  that  134:106-122,  and  the  corresponding  region  of 132  (132:104-I20), 
contributes to an agonist binding site that bridges the a  and non-a subunits. To test 
this  hypothesis, we  have  extended  the  earlier  studies  with  (a)  more chimeric and 
mutated  13 subunits and  (b) electrophysiological measurements of the agonist dose- 
response relationship, which we summarize by the half-maximal agonist concentra- 
tion (ECs0)  and  Hill coefficient (napp).  The results  show that  the region of 134 that 
converts the ECs0 for ACh from a  132-like to a  134-like value overlaps the previously 
localized  region  that  converts  the  CYT/ACh  response  ratios  of 134  NH2-terminal 
chimeras  from  132-like to  134-like values  (Figl  et  al.,  1992)  and  suggest  that  an 
important component of the agonist binding site lies within the first 120 residues of 
132  and  the  corresponding region  of 134. Some of our results  have  been reported 
previously in abstract form (Figl, Cohen, Gollub, Davidson, and Lester, 1993). 
METHODS 
Construction of the ~ Chimeras and Mutants 
We created chimeras between the 132 and 134 subunits by taking advantage of shared restriction 
sites  in  the  two  subunits  and  using  the  polymerase  chain  reaction  (PCR) to  generate 
overlapping cDNA fragments (Higuchi,  1990) from the two subunits. Fig. 1 shows an alignment 
of 132 and 134 amino-acid sequences. Most of the chimeras contained the NH2-terminal region 
from one  13  subtype joined  to  the  succeeding  COOH-terminal residues  from the  other 13 
subtype  (NH~-terminal  chimeras).  We  refer to  the  NHe-terminal  chimeras  in  the  text by COHEN ET AL.  Agonist  Activation of Neuronal nAChRs  747 
FIGURE  1.  The aligned amino acid sequences of the rat [32 and [34 neuronal nAChR subunits. 
The boxes outline identical residues and the shading denotes homologous residues.  Residue 1 
begins  after  the  termination  of the  leader  sequences  (not  shown).  The  arrows  above the  [34 
sequence  point  to  the  transitions  in  the  [34  NH2-terminal  chimeras  between  the  [34  and  IB2 
sequence. The arrows beneath the [32 sequence point to the transitions in the [32 NH2-terminal 
chimeras between the [32 and  [34 sequence. The numbers above (below) the arrows are the last 
residues  in  the  B4  ([32) NHz-terminal  regions  of the  chimeras,  The  lines  beneath  the  [32 
sequence denote the transmembrane  regions M1-M4. 748  THE JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  105  ￿9 1995 
transition points between the two types of 13 subunits. For example, 132(229)'134 is a chimera 
containing the first 229 residues of 132 joined to residues 232-475 of 134 (see Fig.  1). Chimeras 
containing  internal substitutions are labeled by the end points of the substitution. For example, 
134"132(104-120)'134 is a chimera in which we substituted 132:104-120 for residues 106-122 of 
the 134 subunit (these labels have been shortened to 132(104-120) and 134(106-122) in Figs. 7 
and 8). 
To create  the  132(229)'134 and 134(231)'132 chimeras, we  excised  the  cDNA fragments for 
residues 132:1-229 and 134:1-231 from the wild-type subunits with EcoRI and BbsI, subcloned 
the excised fragments into the complementary restricted plasmid from the opposite 13 subunit, 
and  sequenced  the  region  around  the  134/132 transition to  check  the  final product.  The 
remaining chimeras were constructed in three steps:  (a) we synthesized two or more separate 
PCR fragments; (b) we annealed and amplified the PCR fragments; and (c) we  inserted the 
annealed fragment into the appropriate restriction sites in the wild-type plasmid. We normally 
introduced a  silent mutation into the chimera during the initial PCR reaction to allow us to 
check the final product by restriction analysis.  In addition, all the chimeras were verified by 
DNA  sequencing. We  made  point mutations using the  Altered  Sites  Kit  (Promega  Corp., 
Madison, WI) and verified the mutations by restriction analysis and DNA sequencing. Point 
mutations are  denoted in the  text by subscripts that contain the  single letter code for the 
original residue,  followed  by its  position in the  sequence, and the  residue to which it was 
mutated. We synthesized mRNA in vitro using the MEGAscript  Kit (Ambion, Austin, TX) or a 
previously published method  (Guastella, Nelson, Nelson, Czyzyk, Keynan, Midel,  Davidson, 
Lester,  and Kanner,  1990)  and checked  the  size  of the  synthesized mRNA by agarose  gel 
electrophoresis. 
Oocyte Expression 
Stage V-VI Xenopus oocytes were isolated as described previously (Quick and Lester, 1994) and 
injected with mRNA in a  stoichiometric ratio for 0L:13 of 2:3.  The amount of mRNA injected 
(< 25 ng/subunit)  was adjusted to maintain a maximum response (/max) of < 10 ~  at -50 inV. 
Before  recording, the oocytes were incubated for 2-7 d at 18~  in a modified Barth's solution 
supplemented with 50 ~g/ml gentamicin, 2.5 mM pyruvate, and 5% horse serum (Quick and 
Lester,  1994). 
Electrophysiological Recordings 
The oocytes were voltage clamped at -50 mV with two, 3 M KCl-filled microelectrodes made 
from thick-walled  borosilicate glass (model BF150-86-10, Sutter Instrument Co.,  Novato, CA) 
and  an  AxoClamp  2A  voltage  clamp  (Axon  Instruments,  Foster  City,  CA). During  the 
experiments, we  perfused the  recording chamber (~ 1.5  ml vol) with 98  mM  NaCl,  1 mM 
MgC12, and 5  mM HEPES  (pH  7.4)  at room temperature (20-24~  at  10-20 mi/min. We 
omitted Ca  ~+ from the recording solution because the entry of Ca  2§ through neuronal nAChRs 
can  activate  the  endogenous Ca2+-activated  C1-  current  of the  oocyte  (Vernino, Amador, 
Leutje, Patrick,  and Dani, 1992). 
We applied agonists to the oocytes by pinching-off  the outflow of a U tube (Bormann, 1992) 
with a  solenoid-activated pinch valve (Cole-Palmer, Niles,  IL) under computer control. The 
time  constant  of  the  approach  to  a  steady  state  response  ('to,) was  0.4-0.5  s  at  slowly 
desensitizing agonist doses.  To check the effective  [agonist] reaching the oocyte  from the U 
tube, we applied a slowly desensitizing dose of ACh (1 IxM) to an oocyte expressing (x3132 using 
the bath and U tube perfusion systems.  Bath and U tube application of 1 v.M ACh produced 
the  same  steady  state  response.  Endogenous  muscarinic responses  were  rare  and  easily 
identified by their oscillatory  nature and delayed onset after agonist application from the U 
tube. We did not use oocytes exhibiting muscarinic responses. COHEN ET AL.  Agonist Activation of Neuronal nAChRs  749 
Collection and Analysis  of the Dose-Response Data 
We recorded  the  responses  to  6-11  different agonist doses  to  measure  the  dose-response 
relationships for  individual oocytes. The  agonist was  applied in  6-s  pulses  separated  by a 
2-3-rain rinse with control saline. The  responses were filtered at  20  Hz and  digitized at a 
sampling  frequency  of 50  Hz  using  an  MS-DOS  computer  equipped with  pCLAMP V5.5 
software (Axon Instruments). 
We fit the dose-response data for individual oocytes to the Hill equation, 
/max 
/peak  =  {ECsoInapp  ' 
I+~[AI] 
where  Ip~k was  the  peak  response  at  agonist concentration  [A],  using weighted  nonlinear 
least-squares regression. To reduce the interdependence of the parameters/max, ECs0, and napp, 
we allowed only the /max and the ECs0 to vary when fitting to the Hill equation. The napp was 
fixed at  the  mean  slope of the  Hill plots for the  receptor subtype being fit. The  napp was 
determined  (a)  from  the  Hill  plot  by  linear  regression  of log[lp~,/(I,~- lp~ak )]  against 
Iog[agonist] where/max was the maximum observed response and (b) from the log-log plot by 
regression at the foot of the dose-response relationship. The  correlation between these two 
measurements of the napp was 0.89 for the 26 receptor types discussed in the text. Regression of 
the log-log slope against the corresponding Hill slope predicted a log-log slope of 1.1 for a 
Hill slope of 1.0 and a log-log slope of 1.9 for a Hill slope of 2.0. We preferred the estimates of 
the napp from the Hill plot because (a) the slope of the Hill plot was based on more points per 
oocyte than the initial log-log slope measurements,  (b) log-log slope measurements tend to 
underestimate  the  true  napp, (c)  the  Hill  plot  included  more  data  points  with  a  higher 
signal/noise ratio than the initial log-log plot, and (d) the n~pp'S from the Hill plot generally fit 
the dose-response relationship better than the napp'S  from the log-log plots. The napp'S  reported in 
the  text  are from  Hill slopes rather  than  from  log-log slopes unless  stated  otherwise. We 
weighted the residuals by 1/~/Ipeak  for the fit to the Hill equation because the variance of Ipe~, at 
the high end of the dose-response relationship was larger than the variance of lp,a at the low 
end. Repeated measurements on a single oocyte showed that long-term desensitization reduced 
the/ma~ but did not affect the ECs0 or n~pp. 
To compare measurements of the ECs0 with widely different variances, we transformed the 
ECs0's to log values. Unless otherwise stated, the measurement errors reported in the text are 
standard deviations (SDs) and the SDs for the ECs0's given in the text are for untransformed 
data. To construct normalized dose-response relationships for the receptors, we normalized the 
individual dose-response relationships to the fitted lm.~'S and pooled the resulting data. We 
then  refit  the  Hill  equation  allowing only  the  ECs0 to  vary.  The  error  reported  for  the 
normalized ECs0 measurements is the standard error of estimate (SEE). 
Correction of the Peak Response for Desensitization 
Rapid desensitization reduces the peak response because some receptors desensitize while the 
[agonist] is still rising around the oocyte. We used the following three-state scheme (Scheme I) 
to calculate depression of the peak response by rapid desensitization, 
kl  k2 
C---~O--->D, 
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where C, O, and D are the closed, open, and desensitized states of the receptor, k~ is the rate 
constant for the [ACh]  to reach a  steady state around the oocyte, and k 2 represents the rate 
constant for desensitization. We obtained kj directly from the rate constant of the rising phase 
of the response with  1  ~M ACh and k 2  directly from  the rate constant of the decay of the 
response within the agonist pulse (in  the Results section,  1/kl  and  1/k2  are termed Ton and 
~de~n). The relationship between the peak amplitude of the observed response (/peak)  and the 
peak amplitude of the calculated response (Icalc)  is, 
peak 
/calc  =  kl  [[kl]kl/(k2_kl  ,  {kl]k2/(k2_k,)  ]  (1) 
k2 -  kl [~k2]  -  ~2]  J 
At high [ACh]'s, the decay of the response consisted of two exponential components. These 
components  were  corrected  separately using  Eq.  1  and  then  summed  to  obtain  the  final 
calculated peak response. 
RESULTS 
The  [3 Subunit  Affects  the Agonist  Dose-Response  Relationship 
Consistent with previous data (Couturier et al., 1990; Leutje et al., 1993; Wong et al., 
1993),  we  found  that  the  13  subunit  profoundly  affects  the  sensitivity of neuronal 
nAChRs  to  ACh.  Expressing  a3  with  [32,  instead  of  with  [34, shifted  the  ACh 
dose-response relationship at  -50  mV considerably to the left and reduced its slope 
(Fig. 2). The traces in Fig. 2,  A and B, are typical ACh responses of ~t3132 (Fig. 2 A  ) 
and ~x3134 (Fig. 2 B) from oocytes with similar maximum  responses. We fit the ACh 
FIGURE 2.  (opposite)  Expressing  et3  with  [32, rather  than  with  [34, reduces  the  EC~0 and 
apparent Hill coefficient (napp) of the ACh dose-response relationship. (A) Responses of a3132 to 
1-300 o~M ACh. The numbers are the [ACh]  in o,M. The square pulse above the traces is the 
duration of the application of ACh from the U  tube. (B) Responses of ~t3[$4 to 20-1,000  ~M 
ACh.  (C)  Dose-response  plots  for  ~t3152 and  oL3[M. The  symbols  denote  different  oocytes 
expressing ~t3[32 (filled circles, open  circles, filled  inverted  triangles,  open  reverted  triangles,  filled 
squares) or ~t3134 (open squares, filled upright triangles,  open upright triangles). The lines are fits to 
the Hill equation  (see Methods). The  EC50's and  the /max'S  are  17  ~M  and  1,863  nA (filled 
circles),  13 ~M and  1,757 nA (open circles),  15 ~M and 2,056 nA (filled inverted triangles),  9  ~M 
and 1,461  nA (hollow inverted triangles),  13 ~M and 1,498  nA (filled squares), 216 o,M and 1,944 
nA (open squares), 232 o.M and 2,061  nA (filled upright triangle),  and 209 ~M and 2,100 nA (open 
upright triangle).  Voltage =  -50 mV. (D) Hill plots for the peak ACh responses (/peak)  of ct3[32 
and ~t3[M. /max  is the maximum observed /peak.  The  symbols denote different oocytes; ot3132 
(filled circles, hollow circles),  tx3134 (filled inverted triangles,  hollow inverted triangles,  filled squares). 
Overlap obscures some of the data. The napp'S are  0.9 (filled circles),  1.0 (open circles),  2.2 (filled 
inverted triangles),  2.3 (inverted triangles),  and 2.2 (filled squares). (E) Log-log plots of the foot of 
the ACh dose-response relationship show that  the slope of the ct3[34 log dose-log response 
relationship is ~ twice that of ~t3[32. The symbols represent data from six oocytes (each oocyte is 
represented by a different symbol). The lines are regression lines fit to the log-log data. The 
slopes for ct3134 are 2.0  (filled circles),  2.0  (open  circles),  and  1.8  (filled inverted  triangles);  the 
slopes for ot3132 are !. 1 (hollow inverted triangles),  1.0 (filled squares), and  1.0 (hollow squares). COHEN  ET AL  Agonist Activation  of Neuronal nAChRs 
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dose-response relationships for et3l~2 and a3134 to the Hill equation (Fig.  2 C) using 
the napp'S for a3132 and a3134 determined from Hill plots of the ACh responses (Fig. 
2 D). Similar to previous results (Couturier et al.,  1990;  Leutje et al.,  1993; Wong et 
al.,  1993), the ECs0 for ACh was 11  -  4  ~M (mean _+ SD, n  =  29 oocytes) for the rat 
a3132 receptor and 219 -+ 12 txM (n =  3) for the rat et3134 receptor. The nap  p for a3[~2 
was  1. I  _  0.2  (n =  29) and the napp for a3134 was 2.2  -+ 0. I  (n =  3).  Fig.  2 D  shows 
Hill plots for the two receptors. Measurements of the napp from the initial slope of a 
log-log  plot  of the  dose-response  relationship  (where  desensitization  and  agonist 752  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  105  ￿9 1995 
self-block are minimal) gave similar, but slightly smaller, napp'S for cx3132 (0.9 +  0.1, 
n  =  11) and ~3134 (1.9 +  0.1, n  =  3). Fig. 2 E  shows examples of the initial portions 
of the  log(dose)-log(response)  relationships  for  the  two  wild-type  receptors.  The 
agreement of these  measurements  shows  that  the  difference between  the napp'S of 
cx3132 and ~3134 was not due to desensitization or open-channel block by the agonist. 
Injecting  equal  amounts  of  mRNA  generally  gave  much  larger  maximal  ACh 
responses for ~x3134 than for cx3132 ( ~  10-fold) but we did not study these differences 
further. 
The dose-response relationships of ~x3[32 and r  for TMA displayed differences 
comparable to,  but less pronounced  than,  those  for ACh  (Fig.  3).  Fig.  3, A  and B, 
shows  sample  responses  of cx3132 (Fig.  3A)  and  ~x3134 (Fig.  3B)  to  TMA.  Rapid 
desensitization  is  less  pronounced  for  both  wild-type  receptors  with  TMA  as  the 
agonist. The ECs0  of cx3[32 for TMA (76 -- 11  o~M, n  =  7) was fivefold smaller than 
that of cx3134 (424 --- 94 p,M, n  =  6) and the napp of r  for TMA (1.4 -+ 0.1, n  =  7) 
determined from Hill plots of the dose-response data was significantly smaller than 
the  napp  of r  (2.0  -- 0.2,  n  =  6).  As with  ACh,  the  [32  subunit  shifts  the  TMA 
dose-response  considerably  to  the  left  (Fig.  3 C).  Thus,  the  [3  subunit  affects  the 
activation  of neuronal  nAChRs  by  an  agonist  that  contains  only  the  quaternary 
ammonium portion  of the ACh  molecule;  and  the  effects of the  [3  subunit  on  the 
agonist dose-response relationship persist even with an agonist that desensitizes the 
receptor more slowly than ACh. 
Rapid Desensitization Fails to Account for Differences in the ECso'S of o_3[32 
and a3134 
The response of cx3132 to ACh (Fig. 2 A) desensitized more quickly than the response 
of ~3~4 to ACh (Fig. 2 B). The time constant %n for activation of the ~3132 response 
to  1 p~M ACh to reach a  steady state was 0.4-0.5  s. The time constant "rdesen for the 
desensitization of the a3~2 response decreased from 5-7 s at 3 ~M ACh to 0.6-0.8 s 
at 300  ~M ACh. Desensitization of the ~3132 response to 300  p-M ACh was biphasic 
with  an additional  slow time constant  of 5-6  s.  The ~3~4  receptor displayed  little 
desensitization during the 6-s agonist pulse. The ~desen for ~3~4 was 5-6 s at 1-2 mM 
ACh and was too slow to measure at 20-500  ~M ACh. 
We  corrected  the  peak  ACh  response  of the  wild-type  receptors  for  apparent 
desensitization  (see  Methods)  and  fit  the  corrected  data  to  the  Hill  equation  to 
determine how much of the difference in the ECs0's could be due to a  difference in 
the  rate  of desensitization.  Correcting  the  peak  response  of ~3132 for  apparent 
desensitization left napp unchanged but increased the ECs0 of ~x3[~2 for ACh twofold. 
Desensitization of ~3~4 did not significantly affect the ACh dose-response relation- 
ship. Thus, allowing for the potential effects of desensitization,  the ECs0 of ~3134 for 
ACh was still 10-fold larger than the ECs0 of ~3132. The differences in desensitization 
accounted  for  such  a  small  fraction  of the  differences  between  the  EC50's  of the 
wild-type receptors that we decided not to attempt to correct the amplitudes of the 
peak responses. We were unable to resolve desensitization occurring on a  time scale 
faster than 1 s (Maconochie and Knight, 1992) using our drug application system (see COHEN ET AL.  Agonist Activation  of Neuronal nAChRs  753 
Methods).  Such desensitization  would produce  an apparent  decrease  in the  ECs0 of 
the dose-response  relationship  in our experiments. 
NH2-Terminal  Substitutions of 105 or More  [34 Residues Increase the ECso for ACh 
Substitutions  of 94 or fewer  134 residues  had only small effects  on the  ECs0 for ACh 
(Fig. 4 A); the ECs0's of the et3134(16)'132,  et3134(81)-132,  and ot3134(94)-132  chimeras for 
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FIGURE 3.  Expressing a3 with 134, rather than with 132, increases the ECs0 and the nap  p of the 
TMA dose-response relationship. (A) Responses of et3132 to 5-200 I~M TMA. The responses are 
labeled with the [TMA] in IxM. The square pulse above the traces  shows the timing of the TMA 
application.  (B) Responses of a3134 to 50-2,000  o~M TMA.  (C)  Expression with 134 shifts  the 
TMA dose-response  relationship  to the right  and increases  its  slope.  The symbols are mean 
normalized responses  +_ SD. The ECs0's of the TMA dose-response relationships for ot3132 and 
ot3134 are 75 -  3  o,M (n =  7) and 416  _  12 I~M (n =  6) (- standard error of estimate,  -+SEE). 
ACh (13-18  I~M) were within a factor of two of the ECs0 of ct3132 for ACh. However, if 
the 134 NH2-terminal  region of the chimeras was extended  from 94 to  109 residues, 
the ECs0 for ACh increased dramatically to a  134-like value.  Fig.  4 B  presents  data for 
the interesting  region between  residues  134:94  and  134:109  and  shows the rightward 
shift  of the  normalized  ACh  dose-response  relationships  as  more  [34  residues  are 754  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  105  ￿9 1995 
included.  All  the  [34  NH2-terminal  chimeras  with  113  or  more  [34  NH2-terminal 
residues displayed [34-like EC50's for ACh (> 10-fold larger than that of a3132). Thus, 
the  [34/[32  residue  substitutions  necessary  for  [34-like ACh  sensitivity in  the  [34"[32 
chimeras lie in the first  113 residues of [34. 
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FIGURE 4.  (A)  Substituting  105  or more  [34  NH2-terminal residues for  the  corresponding 
region of [32 increases the ECs0 for ACh. The horizontal axis is the number of [34 NH2-terrninal 
residues in the chimera: zero for cx3132 and 475 for et3134. The symbols are the mean values for 
the two wild types and  14  [34"[32 chimeras (n =  2-29 oocytes). Overlap obscures some of the 
data. The dashed lines are 1 -+ SD. The means and SDs for the ECs0'S were computed from log 
transformed data. The vertical line denotes  the  beginning of M1.  (B)  The  addition of two 
residue  substitutions in  the  [34:95-109  sequence  (see  Fig.  1)  shifts  the ACh  dose-response 
relationship dramatically to the right. The symbols are the mean normalized responses -+ SD 
(see Methods) for ~3134(94)'[32, ~x3134(105)'[32, and ~3134(109)'[32. The lines are fits to the Hill 
equation (see Methods). The ECs0'S for ACh are 16 _  1 I~M (n =  9),  60  -  4  ~M (n =  4), and 
338  -+ 23  [~M (n =  6), respectively (_+SEE). (C) Substituting >301  [34 NH~-terminal residues 
increases the nap  p for ACh to  > 2.0. 
There  are  only  two  [34/[32  residue  substitutions  in  [34:95-109  (see  Fig.  1).  The 
addition  of  these  two  substitutions  increased  the  ECs0  of  the  [34  NH2-terminal 
chimeras  from  [32-like  to  [34-like  levels.  Therefore,  we  made  the  site-directed 
mutations  [32M101T.I:106v tO change just these residues in the [32 subunit. The ECs0 of COHEN ET AL.  Agonist  Activation of Neuronal nAChRs  755 
the mutated receptor for ACh (19 +- 4  I,M, n  =  5) was within a  factor of two of the 
value for cx3152 (11  -+ 4  ~M). Thus, the increase in the EC~0 of or3154(109)-[32 over the 
ECs0 of cx3154(94)'[32 depended on residue substitutions within the first 94 residues of 
[54 in addition to the two substitutions  [32:Met101~--~[54:Thr103  and [52:Phe106~--H34: 
Vail08. Previous experiments (Chiara et al.,  1992; O'Leary, Filatov, and White,  1994) 
also  suggest  that  a  tryptophan  (,/:Trp55,  ~:Trp57)  in  the  first  60  residues  of the 
non-or subunits contributes to the agonist binding sites of the Torpedo nAChR. 
We also made the mutation a3134(61)SZ8N'[32 to determine if the loss of a potential 
glycosylation site at [52:Asn26 was responsible for the slight decrease in the EC50 of 
0t3154(61).[52 below that of ct3152. The  ECs0 (6 -+ 3  tzM,  n  =  4)  and napp (0.8  •  0.1, 
n  =  4)  of Ct3154(61)SZSN'[52 for ACh  were  not  significantly  different  from  the  ECs0 
(5 -+  1 IrM, n  =  6) and the nap  p (1.0 4- 0.1, n  =  6) of or3154(61)'[52. Thus, the removal 
of a  potential  glycosylation  site  at  [52:Asn26  was  not  responsible  for the  effect of 
ct3134(61)'[32 on the EC50 for ACh. 
Increasing the nat~ to [34-like Values Requires  an Extensive  Region of [34 
The  nap  p of the  [54"[52 chimeras showed a  more gradual dependence  on the  [54/[32 
transition point than the EC50. The napp'S of these chimeras fell into three categories, 
[52-like (napp =  1.0-1.2),  intermediate (napp  =  1.6),  and [54-like  (napp =  2.0-2.2). The 
chimeras containing  109  or less  [54  NHz-terminal residues  exhibited  [52-like  napp'S; 
the chimeras containing  109-231  [34 NHz-terminal residues  exhibited  intermediate 
napp'S except for cx3134(122)'[52 (napp =  1.2  +  0.2,  n  =  2);  and the chimeras contain- 
ing 301  or more [54 NHz-terminal residues exhibited [54-like napp'S. The [52MI01T, F106V 
mutation did not affect the napp for ACh. 
We are not surprised by the differences between the regions of [54 that affect the 
ECs0 and those that affect the napp. Areas of contact between the subunits outside the 
agonist binding  site  may affect the  cooperativity of a  multisubunit  receptor (Kosh- 
land, Nemfithy, and Filmer,  1966). Nevertheless, the overlap between the [54 residues 
that increase the EC50's of the [34.[52 chimeras and the residues that increase the napp 
from [52-like  to intermediate values suggests that [54:106-122  and [52:104--120  may 
be  areas  where  the  ct  and  [5  subunits  contact  each  other.  The  results  for  the  [54 
NH2-terminal  chimeras  also  suggest  that  these  subunits  contact  each  other  some- 
where  between  the  end  of the  first  putative  transmembrane  domain  M1  and  the 
initial portion of the M3-M4 intracellular loop. However, our data do not allow us to 
exclude the alternative hypothesis that these residue substitutions produce a confor- 
mational change in the receptor that affects cooperativity indirectly. 
Substituting fl2:1-120 for the Corresponding  Region of [34 Reduces  the ECso 
to a  [32-like Value 
We  constructed  a  number  of [52-[54 chimeras  to  determine  the  region  of the  [52 
subunit  required  to  reduce  the  ECs0  of the  chimeras  to  [32-like  values  (Fig.  5 A). 
Similar to results for the [54"[52 chimeras, substituting the first 120 residues of [52 for 
the  corresponding  region  of [54 reduced  the  ECs0 for ACh  to  16  4-  8  IxM (n =  3) 
which  resembles  the  ECs0  of ct3152 (11  4- 4  izM).  Fig.  5 B  shows  the  effect of this 
substitution on the ACh dose-response relationship. Substituting the first 92 residues 
of [52 also reduced the ECs0 for ACh (Fig. 5 A). Thus, residue substitutions in the first 756  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  105  ￿9 1995 
92 amino acids of 62 do affect the sensitivity of the receptor to agonist but this effect 
is masked in the  64  NH2-terminal chimeras. 
There  is an  anomalous  member of the  ~2"[M  series;  the  ECs0 of ct362(229)'[M  for 
ACh was close to that of ct364  (Fig.  5 A  ). This anomalous  ECs0 does not seem to be 
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FIGURE  5.  (A)  132 NH2-terminal substitutions have a more complex effect on the ECs0 for ACh 
than 134 NH~-terminal substitutions. The symbols are mean values for the two wild types and 
five  132  NHe-terminal  chimeras  (n =  3-29).  The  dashed  lines  are  -+  SD.  The  vertical  line 
denotes the beginning  of M 1.  (B) Substituting  [32:1-120  for the corresponding region of 64 
reduces the ECs0 to a [32-like value. The symbols are the normalized responses -+ SD. The lines 
are fits to the Hill equation. The ECs0's for ~t3132(120)'~4  and (~3~4 are 15 _  3 p~M (n  =  3) and 
215  _+  8  ~M  (n =  3) (- SEE).  (C) Substituting 93  or more 132 NH2-terminal residues for the 
corresponding regions of 134 reduces the nap  p for ACh to ~2-1ike values. 
due  to a  disruption  of the agonist binding  site. Previous data  show that this chimera 
displays  a  62-like  affinity  for the irreversible  competitive inhibitor,  neuronal  bunga- 
rotoxin  (Papke,  Duvoisin,  and  Heinemann,  1993),  and we found  that (~362(229)'~4 
exhibits a  clear [32-like insensitivity to CYT relative to ACh  (Fig.  6). 
Thus,  the  results  for  the  64  and  62  NH2-terminal  chimeras  show  that  132/134 
substitutions  in  the  first  120  residues  of  132  and  the  first  113  residues  of  {34  are 
sufficient  to convert the ECs0 for ACh from one wild-type value to another. COHEN ET AL.  Agonist  Activation of Neuronal nAChRs  757 
Short [32 NH2-Terminal Substitutions Disrupt the Cooperativity of the Receptor 
[$2  NH2-terminal sequences of 92  or more residues  reduced  the napp for ACh  to a 
value near that of ~3[$2  for ACh (1.1  -  0.2)  (Fig. 5 C).  Moreover, a  single measure- 
ment of the napp (1.1)  for 0~3[$2(59)'[$4 from the  initial portion of the log-log dose 
response relationship  suggests that even substituting  the first 59 residues  of [$2 for 
the corresponding region  of [$4 may suffice to reduce  the napp of the chimera to a 
[$2-1ike value. Thus,  as for the [$4 NH2-terminal chimeras, changes in the ECs0'S of 
the [$2 NH2-terminal chimeras were not synchronous with changes in the napp. If the 
napp  is  determined  by  areas  of contact  between  the  subunits,  then  these  results 
suggest  that  an  extensive  region  of  subunit/subunit  contacts,  particularly  at  the 
NH2-terminals of the ~3 and [$4 subunits, are required for the receptor to display the 
strong  cooperativity  observed  for  the  0t3[$4 receptor.  The  small  napp of  the 
~3[$2(120)-[$4  raises  the  possibility  that  there  may  also  be  heterogeneity  in  the 
assembly of this receptor. The ~3[$2(92)'[$4 and ~3[$2(229)-[$4  chimeras also display 
Hill coefficients that are slightly  < 1. 
A ~3#2(229)-#4  B ~5#2 
Agonlst  Agon~st 
l  f~'30  <#'M  AC  h-- L//~----- 
C ~,3,84(231)'#2  D o~,3/24 
FIGURE 6.  The  ~3[$2(229)'[34  chi- 
mera displays a [32-like insensitivity to 
30  ~M  CYT  relative  to ACh.  (A-D) 
Responses to 30 ~M CYT and 30 ~M 
ACh  at  -50 inV. The square pulses 
above the  traces denotes  the release 
of agonist from the U tube. 
Exchanging Just [32:104-120  and [34:106-122  Shifts the ECso 
in the Expected Direction 
Mutations  show  that  the  two  [$4/[$2 substitutions  [$2:Metl01<--~[$4:Thrl03  and  [$2: 
Phel06<--~[$4:Vall08 are not sufficient to change the ECs0 of the ACh dose-response 
relationship. We therefore constructed the reciprocal chimeras a3[$4"[$2(104-120)'[$4 
and a3[$2-[$4(106-122)-[$2  to test whether  more extensive substitutions  in  this area 
could affect the ECs0 for ACh. Exchanging [$2:104-120  and [$4:106-122  shifted the 
ECs0 for ACh  towards  the opposing wild-type value  (Fig.  7,A  and B).  Substituting 
[$2:104-120 for the corresponding region of [$4 reduced the ECs0 for ACh to 90 -  20 
~M  (n =  4),  a  value  less  than  half that  of o~3fl4 (219 -  12  ~M).  The  reciprocal 
substitution  ([$4:106-122  for  the  corresponding  region  of [$2) increased  the  EC~0 
about threefold over the ECs0 for a3[$2,  to 28  -+ 6  ~M  (n =  8). Consistent with the 
results for the  [$2 and [$4 NH2-terminal chimeras,  substituting  [$2:104-120  reduced 
the cooperativity of the chimera to 1.3  +  0.1  (n  =  4) while the reciprocal substitution 
did not significantly increase the napp for ACh (1.3  -  0.2, n  =  8). Thus, eight residue 758  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  105  ￿9  1995 
substitutions  in [32:104-120  and 134:106-122  (see Fig.  1) had an effect on the ECs0 
and napp for ACh that was independent of substitutions elsewhere in the [3 subunits. 
Substituting [32:104-120 for [34:106-122 Also Affects Agonist Selectivity 
Previous  data  (Figl  et  al.,  1992)  show  that  extending  the  [34  region  of  a  134 
NH2-terminal chimera from 134:1-105 to [34:1-122 increases the 30 ixM CYT/30 IxM 
ACh  (CYT/ACh)  and  100  t~M TMA/30  tzM ACh (TMA/ACh)  response ratios from 
[32-like  to  134-like levels.  We  tested  the  effects  of  exchanging  132:104-120  and 
134:106-122  to determine whether these regions accounted for the effects of the 134 
NH2-terminal chimeras on agonist selectivity. 
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FIGURE 7.  Exchanging  132:104-120  and 
134:106-122 shifts the EC~0 of the ACh dose- 
response relationship in the appropriate di- 
rection.  (A)  Substituting  132:104-120 for 
134:106-122  shifts  the ACh  dose-response 
relationship to the right of the ~3134 dose- 
response relationship.  (B)  Substituting  [34: 
106-122  for  132:104-120  shifts  the  dose- 
response relationship to the left of the ~3132 
dose-response relationship. 
Substituting  [32-104-120  for [34:106-122  reduced  the  CYT/ACh  and TMA/ACh 
response  ratios  to  132-like values  (Fig.  8, A  and  B),  but  the  reciprocal  substitution 
[34:106-122  for  62:104-120  produced  only  a  small  increase  in  the  CYT/ACh  or 
TMA/ACh response ratios toward  134-like values. Thus,  similar to the effects of [32 
substitutions on cooperativity, short internal substitutions reduce, but do not restore, 
the relative sensitivity of the a3134 receptor to ganglionic agonists such as CYT and 
TMA.  The  structural  basis  for this  correspondence  between  the  effects of internal 
substitutions  on  agonist  selectivity  and  cooperativity  is  unclear.  Nonetheless,  the COHEN ET aI~.  Agonist  Activation of Neuronal nAChRs  759 
effects of exchanging 134:106--122 and  132:104-120 on several measurements  associ- 
ated with agonist activation of the receptor suggest that these areas are places where 
the a  and 13 subunits contact to form an agonist binding site. 
The Sole M2 Substitution  Does Not Affect the ACh Dose-Response Relationship 
Dose-response relationships for nAChRs are affected by mutations at several residues 
in the M2 transmembrane domain (reviewed in Karlin,  1993). There is a single 132/134 
substitution  in  the  M2  region  (132:Va1253~--~134:Phe255).  We  made  the  reciprocal 
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FIGURE 8.  Exchanging  132:104-120  and 
134:106-122  changes the ratio of the 30 o,M 
cytisine  (CYT)  and  30  I~M ACh responses 
and the ratio of the 100 I~M tetramethylam- 
monium (TMA) and 30 I~M ACh responses, 
(A) Substituting 132:104-120 for [$4:106-122 
reduces  the  CYT/ACh response  ratio  to a 
132-like value  but  substituting  134:106-122 
for  [32:104-120  only  marginally  increases 
the CYT/ACh response ratio. The solid bars 
are means  •  SD.  (B)  Substituting  132:104- 
120 for 134:106-122  reduces the TMA/ACh 
response ratio to a  132-like value, Substitut- 
ing  [34:106-122  for  132:104-120  increases 
the TMA/ACh response ratio to an interme- 
diate value. 
point mutations  134vz55v and  132v253r to test whether  this  substitution  could shift the 
agonist dose-response  relationship.  Neither mutation  significantly affected the  ECs0 
or napp. The napp of Ot3134F255V was 2.0  --+ 0.1  (n =  3); the napp of ot31327253F was  1.2  + 
0.1  (n =  3);  the  ECs0  of a3134E255v was  231  -  18  IxM  (n =  3);  and,  the  ECs0  of 
a3132v253~ was 9  -  1 IxM (n =  3). 
DISCUSSION 
The data reported  in this  paper describe  the steady state dose-response relations of 
chimeric and mutated  139 and 134 subunits  expressed with the a3 subunit in oocytes. 760  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  105  "  1995 
The  data  show  that  the  first  120  residues  of 132  and  a  comparable,  but  slightly 
shorter,  region  of  134  largely  account  for  the  different ECs0's  of the  wild-type 
dose-response relationships. In the sharpest region of transition, chimeras that differ 
at only two residues have more than a  10-fold difference in the ECs0. However, when 
we  examined  the  corresponding  mutant  132M101T,  F106V  it  retained  the  ECs0  of the 
wild-type 132 subunit.  This important result shows that  the two critical residues are 
interacting with other upstream residues during activation of the receptor. Longer 
substitutions in this region (132:104-120--,134:106-122) do affect (a) the ACh  dose- 
response relationship  and  (b)  the  relative responses  to several ganglionic agonists. 
The domains we have identified that affect the EC50 probably affect agonist binding 
and may contribute to an agonist binding site that bridges the ot and [3 subunits. 
Our experiments also bear on the regions responsible for the cooperativity of the 
receptor (napp). Regions  of the  13  subunits  responsible  for differences in  the  napp 
overlap with, but are not identical to, those responsible for differences in the EC50. 
The 132:104-120 and 134:106-122 regions affect both measures. However, for the 134 
NHz-terminal chimeras,  the  transition from 132-like to  134-like cooperativity occurs 
more gradually than the transition from a  132-like to a  134-like ECs0 and requires an 
extensive NH2-terminal region of the 134 subunit. The high level of cooperativity of 
e~3134 is disrupted by short 132 substitutions. If receptor cooperativity is determined by 
areas  of contact  between  the  subunits  (Koshland  et  al.,  1966),  then  one  of these 
contact regions appears to lie in 132:104-120 and 134:106-122. 
The differences we observed between the ACh dose-response relationships of the 
~x3132 and ~x3134 receptors are similar to those reported previously by Couturier et al. 
(1990), Leutje et al. (1993), and Wong et al. (1993) but differ substantially from those 
reported by Cachelin et al. (1991 ). Cachelin et al. (1991) report a much smaller value 
for the EC50 of a3134 for ACh (30 ~M) and a much larger value for the ECs0 of ~3132 
for ACh (354 IxM). They report similar, but less diverse, napp'S  for the two receptor 
subtypes  (napp  =  1.4 for c~3132; napp =  1.8 for a3134). The reason for this discrepancy 
is unclear but most of the previous measurements, including data from a mammalian 
expression system (Wong et al.,  1993), are consistent with our data. 
The a3132(229)'134 chimera is anomalous because it displays a large,  134-like ECs0 
for ACh even though it includes regions of sequence that confer a  132-like ECs0 in 
another chimera tested.  Nonetheless,  the  a3132(229)'134  chimera exhibits a  132-like 
CYT/ACh response ratio and a  132-like irreversible block by neuronal bungarotoxin 
(Papke  et  al.,  1993).  Based  on  its  agonist  selectivity  and  affinity  for  neuronal 
bungarotoxin, we suggest that the large EC50 of this chimera arises from a change in 
the conformational states of the receptor that enhances  the relative stability of the 
closed  singly  liganded  receptor  state  (Koshland  et  al.,  1966)  rather  than  from  a 
change in the agonist binding site. 
Channel Block by the Agonist Fails to Account for Differences in the Napp 
Measurements  of the  Hill coefficient at the  foot of the  dose-response relationship 
show that the differences between the napp'S of the wild-type receptors are not due to 
channel block by the agonist because open-channel block is minimal in this region. 
However, open-channel block by the agonist could reduce the apparent ECs0 of the 
agonist  dose-response  relationship.  To  assess  the  importance  of this  effect,  we COHEN ET AL.  Agonist  Activation of Neuronal nAChRs  761 
calculated the dissociation constant Ki of agonist for an open-channel blocking site 
that  would  yield  a  [32-like  ECs0,  assuming  that  (a)  the  agonist  can  open  all  the 
channels (a worst-case analysis),  (b) (x3[B2 and (x3[B4 display a  [34-like ECs0  for ACh 
(219  wM)  in  the  absence  of channel block,  and  (c) the  nap p  for cx3B2 is  ~  1.  The 
fractional response of the receptor (Ipeak/Imax) under these conditions is 
/peak  1 
/max  219 wM  [ACh] " 
I+--+-- 
[ACh]  Ki 
A Ki of 10  ~M would be required to bring the ECs0 to 24  ~M. Concentration- and 
voltage-jump experiments on neuronal nAChRs  in bovine chromaffin cells suggest 
that the actual dissociation constant of ACh for the channel blocking site of neuronal 
nAChRs  is  closer  to  700-1,400  ~M  (Maconochie  and  Knight,  1992),  or  70-  to 
140-fold  greater  than  the  value  required  to  bring  the  ECs0  for (x3132 to  24  p~M. 
Moreover, with a Ki of l0 ~M, the maximum response would occur at  ~ 50 p,M ACh. 
Higher agonist concentrations would reduce the amplitude of the response, contrary 
to our data for (x3132 (Fig.  2A). Additionally, the  sole substitution  in  M2,  which is 
thought to contain the binding site for open-channel blockers, has no effect. These 
results strongly suggest that agonist self-block does not account for the differences in 
the ECs0'S that we observed. 
Residues in a Homologous Region of y and 6 Determine Curare Binding 
Three  residue  substitutions  in  the  mouse  ~/  and  5  subunits  ('y:Ilell6(--~5:Valll8, 
~/:Tyrll7(--)~:Thrll9,  ~:Ser161(--)8:Lys163)  account  for  a  10-fold  increase  in  the 
affinity of the  (x[3~/ receptor over the  cx[35 receptor for the  competitive antagonist 
(+)-dimethyltubocurarine (Sine, 1993). Residues [32:Ilel 18 and [32:Phe119 in the rat 
neuronal nicotinic receptor are homologous to ~:Ile116 and ~:Tyrl 17 in the mouse 
receptor  and  they  are  in  the  [32:104-120  domain  of the  rat  neuronal  nicotinic 
receptor.  More  recent  evidence  (Xie,  Chiara,  and  Cohen,  1994)  shows  that  the 
competitive antagonist dTC also photolabels residues ~/:Tyrl 11 and ~/:Tyrl 17 in the 
Torpedo  nAChR  (homologous  to  [32:Ser113  and  [32:Phel19  in  the  rat  neuronal 
nicotinic  receptor).  Thus,  in  a  domain  homologous  to  132:104-120  in  the  rat 
neuronal nicotinic receptor, we  find (a)  residues in the  Torpedo ~  subunit  that are 
photolabeled by dTC  and  (b)  residues  in  the  mouse  "y and  5  subunits  that  affect 
competitive antagonist  binding.  Residues  in  [32:104-120  affect the napp, the  EC~0, 
and agonist selectivity of neuronal nicotinic receptors. The proximity of residues in 
the  muscle-type  nicotinic  receptors  that  affect  binding  and  photolabeling  by  a 
competitive antagonist with those in the neuronal nicotinic receptor that affect the 
napp, the ECs0, and agonist selectivity supports the hypothesis that residues [32:104- 
120 contribute to an ~/[3 ligand binding site in neuronal nAChRs. 
Differences in Channel  Gating  Do Not Account for Differences in the 
Wild-Type ECso 
We consider a simple sequential model to suggest that differences in agonist binding, 
rather than in the rates of conformational change, are primarily responsible for the 762  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  105  ￿9  1995 
difference  between  the  ECs0's  of c~3~2 and  0t3134 for ACh.  This  kinetic  scheme 
(Scheme II) can be summarized as follows, 
nA  +  R  C  ~O  ~  I, 
SCHEME II 
where n is the Hill coefficient, A is the agonist, R  is the free receptor, C is the closed 
agonist-bound receptor, O  is  the conducting state of the receptor, I  is  an agonist- 
bound  inactivated  state  of the  receptor,  and  KI-K3  are  dissociation  constants￿9 At 
equilibrium, the fraction of open receptors Po is, 
Po  -- 
1 +~+K2+  [Aln 
The ECs0 is, 
ECs0 =  K1  +  Ks +  K3K2 ￿9 
According to the data of Papke and Heinemann (1991), Kz =  1.1 and 0.45, and K3 = 
10 and 20 for 0t3~2 and a3~4, respectively. The point here is not the absolute values 
of these numbers, but the fact that they differ by relatively small amounts for the two 
receptors￿9  A similar conclusion is reached from our own kinetic data on voltage-jump 
relaxations, to be published separately. These differences would change the ECs0 by 
less than  twofold. Thus,  differences in the cooperativity of binding and conforma- 
tional  transitions  of 0t3132 and  ct3134 cannot account for the  20-fold difference we 
observed between the ECs0's of the wild-type receptors for ACh. This model suggests 
that the wild-type dissociation constants for agonist binding (K(s) differ by more than 
10-fold. 
Regardless of the particular kinetic model used, the differences between the mean 
open times of the 0t3132 and ct3~4 channels do not account for the differences in the 
ECs0'S ofct3~2 and 0t3~4 for ACh. The open channel lifetime is usually interpreted as 
the rate constant for leaving the open state of the channel￿9 The long open-channel 
lifetime of the  primary a3134 channel  is  75%  greater than  the  long open channel 
lifetime of the primary a3~2 channel (Papke et al.,  1991). All else being equal, this 
difference in open channel lifetime would be associated with a smaller ECs0 for 0t3~4 
than for c,3~2, contrary to the data￿9 
Conclusions 
Our study is the first attempt to determine the regions of sequence that account for 
the differences in the complete agonist dose-response relationship produced by two 
naturally occurring subunits of a channel. Past experiments on binding of antagonists 
or  open-channel  blockers  have  pinpointed just  a  few residues;  however,  channel 
activation  in  response  to  agonists  is  certainly  a  more  complex  phenomenon, 
involving binding, conformational changes, and interactions between the subunits. It COHEN ET AL.  Agonist Activation of Neuronal nAChRs  763 
is  therefore  encouraging  that  clear  trends  emerge  from  the  data.  Our  results 
emphasize  the  involvement  of one  region,  62:104-120,  in  the  binding  event  and 
suggest that a broader region of sequence is involved in the subunit contacts and/or 
conformational changes that open the channel. 
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